New Targeted Drugs Improve Survival in Advanced Prostate Cancer
Two experimental targeted drugs — radium–223 chloride and MDV3100 — helped some men with difficult–to–treat prostate cancer live longer compared to standard care, according to two international studies.
| • | NCI Cancer Bulletin: new drugs for prostate cancer |
| • | Learn more about prostate cancer treatment |
| • | Targeted Cancer Therapies fact sheet |
Cancer Research News
- Mayo Clinic study finds powerful myeloma treatment regimen shows promise for AL amyloidosis
- Sanford-Burhham scientists develop new model of childhood brain cancer
- Stanford scientists identify a treatment regimen that enhances the effectiveness of a breast cancer treatment
Visit the NCI News Center







